MME
ABMD

Meag Munich Ergo’s Abiomed Inc ABMD Stock Holding History

Meag Munich Ergo’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,249
Closed -$390K – 330
2021
Q2 		$390K Sell
1,249
-43
-3% -$13.2K 0.04% 282
2021
Q1 		$412K Buy
+1,292
New +$413K 0.04% 271
2020
Q3 		– Sell
-727
Closed -$176K – 233
2020
Q2 		$176K Buy
+727
New +$146K 0.03% 191
2020
Q1 		– Sell
-669
Closed -$112K – 504
2019
Q4 		$112K Sell
669
-2,247
-77% -$417K 0.01% 498
2019
Q3 		$511K Buy
2,916
+1,236
+74% +$267K 0.03% 469
2019
Q2 		$429K Hold
1,680
– – 0.03% 436
2019
Q1 		$477K Buy
+1,680
New +$558K 0.04% 406

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Meag Munich Ergo's ABMD Position: Q3 2021 in Review

Meag Munich Ergo sold out of Abiomed Inc (ABMD) in Q3 2021, closing a stake of 1,249 shares — an estimated $390K sold.

Meag Munich Ergo first reported a position in ABMD in Q1 2019 and held it in 7 quarters. The position peaked at $511K in Q3 2019. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2021.

  • Meag Munich Ergo reported no remaining Abiomed Inc position as of Q3 2021 after selling out during the quarter.
  • Meag Munich Ergo sold 1,249 Abiomed Inc shares in Q3 2021, an estimated $390K.
  • Meag Munich Ergo first reported a position in Abiomed Inc in Q1 2019 and held it in 7 quarters.
  • Meag Munich Ergo's Abiomed Inc position peaked at $511K in Q3 2019.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2021.

Based on Meag Munich Ergo's 13F filing for Q3 2021, filed 13 Oct 2021.